59 related articles for article (PubMed ID: 33578601)
1. Long-term survival of advanced lung adenocarcinoma by maintenance chemotherapy followed by EGFR-TKI: A case report.
Chen HJ; Shen JM; Lin YN; Du W; Zhou JP; Li QY
Medicine (Baltimore); 2021 Feb; 100(6):e24688. PubMed ID: 33578601
[TBL] [Abstract][Full Text] [Related]
2. Second-line therapy with first- or second-generation tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer patients with T790M-negative or unidentified mutation.
Nishimura T; Okano T; Naito M; Iwanaka S; Ohiwa A; Sakakura Y; Yasuma T; Fujimoto H; D'Alessandro-Gabazza CN; Oomoto Y; Kobayashi T; Gabazza EC; Ibata H
Thorac Cancer; 2021 Apr; 12(7):1067-1073. PubMed ID: 33586356
[TBL] [Abstract][Full Text] [Related]
3. Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors.
Lau SCM; Fares AF; Le LW; Mackay KM; Soberano S; Chan SW; Smith E; Ryan M; Tsao MS; Bradbury PA; Pal P; Shepherd FA; Liu G; Leighl NB; Sacher AG
Clin Lung Cancer; 2021 Jul; 22(4):253-259. PubMed ID: 33582070
[TBL] [Abstract][Full Text] [Related]
4. Allosteric mutant-selective fourth-generation EGFR inhibitors as an efficient combination therapeutic in the treatment of non-small cell lung carcinoma.
Tripathi SK; Biswal BK
Drug Discov Today; 2021 Jun; 26(6):1466-1472. PubMed ID: 33581322
[TBL] [Abstract][Full Text] [Related]
5. MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts.
Zhu K; Lv Z; Xiong J; Zheng H; Zhang S; Jin H; Yu L; Li Z; Zhang J; Li C; Liang P
Aging (Albany NY); 2021 Feb; 13(5):6890-6903. PubMed ID: 33621951
[TBL] [Abstract][Full Text] [Related]
6. Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC.
Wei J; Meng P; Terpstra MM; van Rijk A; Tamminga M; Scherpen F; Ter Elst A; Alimohamed MZ; Johansson LF; Stigt J; Gijtenbeek RPG; van Putten J; Hiltermann TJN; Groen HJM; Kok K; van der Wekken AJ; van den Berg A
Target Oncol; 2021 Mar; 16(2):215-226. PubMed ID: 33606136
[TBL] [Abstract][Full Text] [Related]
7. Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient.
Ribeiro MFSA; Knebel FH; Bettoni F; Saddi R; Sacardo KP; Canedo FSNA; Alessi JVM; Shimada AK; Marin JFG; Camargo AA; Katz A
NPJ Precis Oncol; 2021 Feb; 5(1):5. PubMed ID: 33580193
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancer.
Ohara S; Suda K; Fujino T; Hamada A; Koga T; Nishino M; Chiba M; Shimoji M; Takemoto T; Soh J; Mitsudomi T
Lung Cancer; 2021 Apr; 154():84-91. PubMed ID: 33631449
[TBL] [Abstract][Full Text] [Related]
9. KRAS G12C-Mutant Non-Small Cell Lung Cancer: Biology, Developmental Therapeutics, and Molecular Testing.
Veluswamy R; Mack PC; Houldsworth J; Elkhouly E; Hirsch FR
J Mol Diagn; 2021 May; 23(5):507-520. PubMed ID: 33618059
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of resistance to chemotherapy in non-small cell lung cancer.
Min HY; Lee HY
Arch Pharm Res; 2021 Feb; 44(2):146-164. PubMed ID: 33608812
[TBL] [Abstract][Full Text] [Related]
11. A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation.
Zhou S; Tang W; Wang Q; Zhang X; Jin X; Xu X; Fu J
Onco Targets Ther; 2021; 14():989-993. PubMed ID: 33603403
[TBL] [Abstract][Full Text] [Related]
12. The immune-related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation.
Chen S; Yu M; Ju L; Wang G; Qian K; Xiao Y; Wang X
Cancer Cell Int; 2021 Feb; 21(1):119. PubMed ID: 33602230
[TBL] [Abstract][Full Text] [Related]
13. TROP2 ADC Intrigues in NSCLC.
Cancer Discov; 2021 May; 11(5):OF5. PubMed ID: 33597275
[TBL] [Abstract][Full Text] [Related]
14. Osimertinib in EGFR-Mutated Lung Cancer.
Liang W; Zhong R; He J
N Engl J Med; 2021 Feb; 384(7):675. PubMed ID: 33596364
[No Abstract] [Full Text] [Related]
15. Microsatellite Instability Analysis in Gastric Carcinomas of Moroccan Patients.
Nshizirungu JP; Bennis S; Mellouki I; Benajah DA; Lahmidani N; El Bouhaddoutti H; Ibn Majdoub K; Ibrahimi SA; Pires Celeiro S; Viana-Pereira M; Manuel Reis R
Genet Test Mol Biomarkers; 2021 Feb; 25(2):116-123. PubMed ID: 33596142
[No Abstract] [Full Text] [Related]
16. Long-term progression-free survival in a patient with advanced non-small-cell lung cancer treated with low-dose gefitinib and traditional herbal medicine: A case report.
Lee BJ; Kim KI; Choi CW; Kim JY; Lee JH
Medicine (Baltimore); 2021 Feb; 100(5):e24292. PubMed ID: 33592873
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
Front Oncol; 2020; 10():621435. PubMed ID: 33585249
[TBL] [Abstract][Full Text] [Related]
18. Practical Issues in the Use of Atezolizumab for Patients with Non-Small Cell Lung Cancer: Case Reports and Literature Review.
Cobo M; Rodríguez-Abreu D; Pérez Parente D; Ruiz Gracia P; González JG
Oncol Ther; 2021 Jun; 9(1):41-53. PubMed ID: 33582978
[TBL] [Abstract][Full Text] [Related]
19. Targeting critical kinases and anti-apoptotic molecules overcomes steroid resistance in MLL-rearranged leukaemia.
de Groot AP; Saito Y; Kawakami E; Hashimoto M; Aoki Y; Ono R; Ogahara I; Fujiki S; Kaneko A; Sato K; Kajita H; Watanabe T; Takagi M; Tomizawa D; Koh K; Eguchi M; Ishii E; Ohara O; Shultz LD; Mizutani S; Ishikawa F
EBioMedicine; 2021 Feb; 64():103235. PubMed ID: 33581643
[TBL] [Abstract][Full Text] [Related]
20. Which adjuvant treatment for patients with BRAF
Funck-Brentano E; Malissen N; Roger A; Lebbé C; Deilhes F; Frénard C; Dréno B; Meyer N; Grob JJ; Tétu P; Saiag P
Ann Dermatol Venereol; 2021 Sep; 148(3):145-155. PubMed ID: 33579557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
